Literature DB >> 29850133

The influence of heparin on coagulation function of patients undergoing video-assisted major thoracic surgery.

Gu-Ha Alai1, Han-Yu Deng1,2, Gang Li1, Jun Luo1, Lun-Xu Liu1, Yi-Dan Lin1.   

Abstract

BACKGROUND: Venous thromboembolism (VTE) remains a common complication after major thoracic surgery, especially resection of lung or esophagus cancer. This trial aims to explore the influence of preoperative usage of heparin on coagulation function of patients treated with video-assisted major thoracic surgery.
METHODS: This prospective randomized control trial collected 91 patients who are diagnosed with lung or esophagus cancer intending to accept video-assisted neoplasm resection from June 2016 to May 2017 in West China Hospital, Sichuan University. After admission to hospital, the patients received heparin sodium (unfractionated heparin) 5,000 U twice a day before operation. The change of blood platelet count (PLT), prothrombin time (PT), activated partial thromboplastin time (APTT), thrombin time (TT), fibrinogen (FIB), international normalized ratio (INR) was collected and analyzed at the points of admission to hospital and post-operation.
RESULTS: The mean value of all coagulation parameters (PLT, PT, APTT, TT, INR, FIB) were in normal range both before and after operation. Postoperative PLT and FIB were not significantly different from preoperative PLT and FIB respectively (P>0.05). Preoperative PT, APTT, and INR increased significantly compared to pre-operation respectively (P<0.05). Postoperative TT significantly decreased when compared to preoperative TT (P<0.05). Preoperative and postoperative abnormal rate of PT or APTT or TT or INR (number of abnormal cases/all cases) was not different significantly respectively (P>0.05). Postoperative mean drainage was 240 mL/d, mean time of hospital stay was 7.50 days, drainage tube was maintained for 4.22 days on average.
CONCLUSIONS: All patients underwent video-assisted major thoracic surgery with preoperative use of heparin, there were significant differences in coagulation function after operation. However, mean values of all coagulation parameters stayed normal range clinically. In a word, the method showed no influence on coagulation function clinically.

Entities:  

Keywords:  Heparin; major thoracic surgery; venous thrombosis; video-assisted

Year:  2018        PMID: 29850133      PMCID: PMC5949495          DOI: 10.21037/jtd.2018.04.04

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  21 in total

1.  Malignancies, prothrombotic mutations, and the risk of venous thrombosis.

Authors:  Joseph A Smith
Journal:  J Urol       Date:  2005-10       Impact factor: 7.450

2.  A clinical outcome-based prospective study on venous thromboembolism after cancer surgery: the @RISTOS project.

Authors:  Giancarlo Agnelli; Giorgio Bolis; Lorenzo Capussotti; Roberto Mario Scarpa; Francesco Tonelli; Erminio Bonizzoni; Marco Moia; Fabio Parazzini; Romina Rossi; Francesco Sonaglia; Bettina Valarani; Carlo Bianchini; Gualberto Gussoni
Journal:  Ann Surg       Date:  2006-01       Impact factor: 12.969

3.  Prevalence of venous thromboembolism in elective thoracic surgery.

Authors:  María Teresa Gómez-Hernández; María Rodríguez-Pérez; Nuria Novoa-Valentín; Marcelo Jiménez-López; José Luis Aranda-Alcaide; Gonzalo Varela-Simó
Journal:  Arch Bronconeumol       Date:  2013-03-28       Impact factor: 4.872

4.  The safety profile of preoperative administration of heparin for thromboprophylaxis in Chinese patients intended for thoracoscopic major thoracic surgery: a pilot randomized controlled study.

Authors:  Han-Yu Deng; Chang-Lin Shi; Gang Li; Jun Luo; Zhi-Qiang Wang; Yi-Dan Lin; Lun-Xu Liu; Qing-Hua Zhou
Journal:  J Thorac Dis       Date:  2017-04       Impact factor: 2.895

5.  The occurrence of antibodies to heparin-platelet factor 4 in cardiac and thoracic surgical patients receiving desirudin or heparin for postoperative venous thrombosis prophylaxis.

Authors:  Michael S Avidan; Jennifer R Smith; Lee P Skrupky; Laureen Hill; Eric Jacobsohn; Beth Burnside; Heidi Tymkew; Charles Eby; Ralph Damiano; George J Despotis
Journal:  Thromb Res       Date:  2011-07-26       Impact factor: 3.944

6.  A comparison of low-dose heparin with low-molecular-weight heparin as prophylaxis against venous thromboembolism after major trauma.

Authors:  W H Geerts; R M Jay; K I Code; E Chen; J P Szalai; E A Saibil; P A Hamilton
Journal:  N Engl J Med       Date:  1996-09-05       Impact factor: 91.245

Review 7.  Primary prophylaxis for venous thromboembolism in patients undergoing cardiac or thoracic surgery.

Authors:  Marcello Di Nisio; Frank Peinemann; Ettore Porreca; Anne W S Rutjes
Journal:  Cochrane Database Syst Rev       Date:  2015-06-19

8.  Randomised high- and low-dose heparin prophylaxis in patients undergoing thoracotomy for benign and malignant disease: effect on thrombo-elastography.

Authors:  Saina Attaran; Pavlo Somov; Wael I Awad
Journal:  Eur J Cardiothorac Surg       Date:  2010-02-12       Impact factor: 4.191

9.  Low molecular weight heparin once versus twice for thromboprophylaxis following esophagectomy: a randomised, double-blind and placebo-controlled trial.

Authors:  Jie-Qiong Song; Li-Zhen Xuan; Wei Wu; Jun-Feng Huang; Ming Zhong
Journal:  J Thorac Dis       Date:  2015-07       Impact factor: 2.895

10.  Thromboembolism in patients undergoing thoracotomy.

Authors:  S Ziomek; R C Read; H G Tobler; J E Harrell; J C Gocio; L M Fink; T J Ranval; E J Ferris; D L Harshfield; D R McFarland
Journal:  Ann Thorac Surg       Date:  1993-08       Impact factor: 4.330

View more
  1 in total

1.  Preoperative thromboprophylactic administration of low-molecular-weight-heparin significantly decreased the risk of intraoperative bleeding compared with heparin in patients undergoing video-assisted lobectomy for lung cancer.

Authors:  Gu-Ha A-Lai; Yun-Ke Zhu; Gang Li; Me-Wu-Jia Mai-Ji; Han-Yu Deng; Jun Luo; Ze-Guo Zhuo; Xu Shen; Yi-Dan Lin
Journal:  Ann Transl Med       Date:  2019-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.